[ 1 ] Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388(10055):2023‒38. 链接1

[ 2 ] Sparks JA. Rheumatoid arthritis. Ann Intern Med 2019;170(1):ITC1‒16. 链接1

[ 3 ] Van Vollenhoven R. Treat-to-target in rheumatoid arthritis—are we there yet? Nat Rev Rheumatol 2019;15(3):180‒6. 链接1

[ 4 ] Conigliaro P, Triggianese P, de Martino E, Fonti GL, Chimenti MS, Sunzini F, et al. Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev 2019;18(7):706‒13. 链接1

[ 5 ] Yu C, Li M, Duan X, Fang Y, Li Q, Wu R, et al.; the co-authors of CREDIT. Chinese registry of rheumatoid arthritis (CREDIT): I. introduction and prevalence of remission in Chinese patients with rheumatoid arthritis. Clin Exp Rheumatol 2018;36(5):836‒40.

[ 6 ] Gavigan K, Nowell WB, Serna MS, Stark JL, Yassine M, Curtis JR. Barriers to treatment optimization and achievement of patients’ goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry. Arthritis Res Ther 2020;22(1):4. 链接1

[ 7 ] Crowson CS, Rahman MU, Matteson EL. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol 2009;36(8):1606‒10. 链接1

[ 8 ] Huang RY, Pan HD, Wu JQ, Zhou H, Li ZG, Qiu P, et al. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: a randomized controlled clinical trial. Phytomedicine 2019;57:403‒10. 链接1

[ 9 ] Chen XM, Huang RY, Huang QC, Chu YL, Yan JY. Systemic review and metaanalysis of the clinical efficacy and adverse effects of Zhengqing Fengtongning combined with methotrexate in rheumatoid arthritis. Evid Based Complement Alternat Med 2015;2015:910376. 链接1

[10] Chandrasekharan UM, Wang Z, Wu Y, Tang WHW, Hazen SL, Wang S, et al. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis. Arthritis Res Ther 2018;20(1):123. 链接1

[11] Huffman KM, Jessee R, Andonian B, Davis BN, Narowski R, Huebner JL, et al. Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. Arthritis Res Ther 2017;19(1):12. 链接1

[12] Abdelkarem HM, Fadda LH, El-Sayed EM, Radwan OK. Potential role of Larginine and vitamin E against bone loss induced by nano-zinc oxide in rats. J Diet Suppl 2018;15(3):300‒10. 链接1

[13] Hu Y, Li B, Wen L, He K. Study on the anti-endotoxin effect of sinomenine using an Agilent genome array. QJM 2018;111(3):171‒8. 链接1

[14] Van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 2011;63(1):37‒42. 链接1

[15] Bian X, Li N, Tan B, Sun B, Guo MQ, Huang G, et al. Polarity-tuning derivatization-LC-MS approach for probing global carboxyl-containing metabolites in colorectal cancer. Anal Chem 2018;90(19):11210‒5. 链接1

[16] Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569‒81. 链接1

[17] Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23(5 Suppl 39):S100‒8. 链接1

[18] Trang LE, Fürst P, Odeback AC, Lövgren O. Plasma amino acids in rheumatoid arthritis. Scand J Rheumatol 1985;14(4):393‒402. 链接1

[19] Partsch G, Tausch G, Eberl R. Plasma amino acid level in rheumatoid arthritis and ankylosing spondylitis and its variation during age. Z Rheumatol 1978;37(3‒4):105‒11.

[20] Mäntyselkä P, Ali-Sisto T, Kautiainen H, Niskanen L, Viinamäki H, Velagapudi V, et al. The association between musculoskeletal pain and circulating ornithine: a population-based study. Pain Med 2017;18(6):1145‒51.

[21] Marini JC, Didelija IC, Castillo L, Lee B. Plasma arginine and ornithine are the main citrulline precursors in mice infused with arginine-free diets. J Nutr 2010;140(8):1432‒7. 链接1

[22] Senft AW. Studies in arginine metabolism by schistosomes. II. Arginine depletion in mammals and snails infected with S. mansoni or S. hematobium. Comp Biochem Physiol 1967;21(2):299‒306. 链接1

[23] Curran AM, Naik P, Giles JT, Darrah E. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Nat Rev Rheumatol 2020;16 (6):301‒15. 链接1

[24] Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101(1):273‒81. 链接1

[25] Yoshida M, Tsuji M, Kurosaka D, Kurosaka D, Yasuda J, Ito Y, et al. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis. Mod Rheumatol 2006;16(5):276‒81. 链接1

[26] McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000;27(3):739‒45.

[27] McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN. Excitatory amino acids, TNF-α, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 2004;137(3):621‒7. †† http://www.lipidmaps.org/. 链接1